Pablo Guisado‐Vasco

Dalbavancin in the treatment of different gram-positive infections: a real-life experience

Emilio Bouza, Maricela Valerio, Àlex Soriano et al. · International Journal of Antimicrobial Agents · 2017 · 154 citations

Anti-infective Agents, Health Sciences, Antibiotics +10

Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain

José Manuel Ramos, Verónica Andrea Buonaiuto, Michele Ricci et al. · The Journals of Gerontology Series A · 2020 · 140 citations · Full text

Covid-19 Epidemiology, Epidemiology Of Aging, Logistic Analysis +24

Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections

Laura Morata, J. Cobo, Marta Fernández-Sampedro et al. · Antimicrobial Agents and Chemotherapy · 2019 · 113 citations · Full text

Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)

Pablo Guisado‐Vasco, Sofia Valderas-Ortega, María Maravillas Carralón-González et al. · EClinicalMedicine · 2020 · 98 citations · Full text

Risk stratification for <scp>S</scp>plenic <scp>M</scp>arginal <scp>Z</scp>one <scp>L</scp>ymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases

Carlos Montalbán, Víctor Abraira, Luca Arcaini et al. · British Journal of Haematology · 2012 · 88 citations · Full text